BioBalance Corporation   Report issue

For profit Phase 3
Founded: New York NY United States (1993)
Status: Left NME R&D (2016)

Organization Overview

First Clinical Trial
2004
NCT00194922
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now